Editorial: Translational study for amyotrophic lateral sclerosis treatment

Sven Schröder; Gerhard Litscher; Weidong Pan

doi:10.3389/fneur.2022.1105360

Editorial: Translational study for amyotrophic lateral sclerosis treatment

Front Neurol. 2023 Jan 16:13:1105360. doi: 10.3389/fneur.2022.1105360. eCollection 2022.

Authors

Sven Schröder¹, Gerhard Litscher^{2

3

4}, Weidong Pan^{5

6}

Affiliations

¹ HanseMerkur Center for TCM at the University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine, Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Graz, Austria.
³ Research Unit for Complementary and Integrative Laser Medicine, Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Graz, Austria.
⁴ Traditional Chinese Medicine (TCM) Research Center Graz, Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Graz, Austria.
⁵ Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
⁶ Laboratory of Brain Science, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

No abstract available

Keywords: Vital Capacity; amyotrophic lateral sclerosis; genetic-environmental studies; genotype-phenotype; integrative therapies; translational research.

Publication types

Editorial

Grants and funding

This study was supported by a grant from the Special Health Industry Project of Shanghai Pudong New Area Health and Family Planning Commission (PW2022E-03).